Amwell Projects Lower Revenue of $195M-$205M for 2026 After Asset Divestiture
Amwell forecasts revenue between $195 million and $205 million for 2026, down from $249.3 million in 2025. The decline follows divestitures as the company refocuses on a single technology-enabled care platform. While Amwell aims to break even on cash flow by Q4 2026, analysts note subscription revenue may also decline. The company narrowed its net loss to $95 million in 2025, though revenue decreased approximately 2% year-over-year, influenced by a reduced contract with the Defense Health Agency.
Theia Market Signal Identification - AI Assisted
Amwell anticipates lower revenue for 2026, projecting between $195 million and $205 million after divesting assets. This follows a revenue of $249.3 million in 2025. The company is transitioning to a single platform for virtual care and digital health services, aiming for more predictable software-as-a-service revenue.
Amwell has targeted 2026 to achieve break-even cash flow, expecting this by Q4. In 2025, it reduced its net loss to $95 million but experienced a 2% revenue decline year-over-year. The company's contract with the Defense Health Agency, worth up to $180 million, faces budget restrictions, impacting revenue.
Comments